Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Hemoglobin A1c Testing Devices Market?

The market size for hemoglobin a1c testing devices has witnessed rapid expansion in recent years. This market is forecasted to increase from $2.08 billion in 2025 to $2.32 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.7%. Historically, this expansion can be ascribed to factors like the rising incidence of diabetes, the broader adoption of routine blood glucose monitoring practices, enhanced availability of laboratory diagnostics, increased understanding of glycemic control, and the implementation of standardized diabetes testing protocols.

The market size for hemoglobin a1c testing devices is set to witness substantial growth over the coming years. It is projected to expand to $3.53 billion by 2030, achieving a compound annual growth rate (CAGR) of 11.1%. This anticipated growth throughout the forecast period can be attributed to several factors, including the surging demand for home-based diabetes monitoring, the increasing integration of AI-driven analytics, the expansion of remote patient monitoring, a heightened focus on personalized diabetes care, and the rising adoption of smart diagnostic devices. Prominent trends expected in this period include the growing acceptance of point-of-care HbA1c testing, the increased use of portable and handheld devices, deeper integration with digital diabetes management platforms, the development of rapid and high-accuracy assays, and an enhanced focus on patient-centric monitoring.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9077&type=smp

Which Drivers Are Supporting The Rise Of The Hemoglobin A1c Testing Devices Market?

The escalating incidence of diabetes is projected to fuel the expansion of the hemoglobin A1C testing devices market. Diabetes, a chronic metabolic condition, is characterized by elevated blood glucose levels. Hemoglobin A1C testing provides crucial information on individuals’ average blood glucose levels, which is utilized for diagnosing type 2 diabetes, pre-diabetes, and for effective diabetes management. This capability allows individuals to monitor the disease and make informed treatment decisions to prevent complications. For instance, in June 2024, according to the National Health Service, a UK-based government department, in 2023, the NHS identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, increasing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This marks a significant rise compared to 3,065,825 in 2022, indicating an increase of nearly 20%. Therefore, the rising number of diabetes patients will propel the hemoglobin A1C testing devices market.

What Leading Segments Are Studied In The Hemoglobin A1c Testing Devices Market?

The hemoglobin a1c testing devices market covered in this report is segmented –

1) By Type: Bench Top Device, Handheld Device

2) By Technology: Ion-Exchange HPLC, Immunoassay, Boronate Affinity Chromatography, Direct Enzymatic Assay, Other Technologies

3) By End Use: Hospitals, Pharmaceuticals, Medical Devices, Laboratory Testing

Subsegments:

1) By Bench Top Device: Automated Hemoglobin A1C Analyzers, Laboratory-Grade Analyzers, Multi-Parameter Testing Devices

2) By Handheld Device: Portable Hemoglobin A1C Testers, Point-Of-Care Testing Devices, Smartphone-Integrated Testing Devices

What Trends Are Projected To Support The Growth Of The Hemoglobin A1c Testing Devices Market?

Leading companies in the hemoglobin A1c testing devices market are prioritizing the development of innovative solutions, including at-home or micro-sample HbA1c collection kits. This focus addresses the growing demand spurred by the increasing prevalence of diabetes, the shift towards decentralized care and telehealth, and patient desires for convenient, lower-cost monitoring alternatives. An at-home HbA1c collection kit offers a user-friendly way for patients to perform a small finger-prick blood collection, stabilize the micro-sample for transport, and dispatch it to a certified laboratory for highly accurate analysis. As an illustration, in February 2023, Hurdle, a US-based diagnostics-as-a-service firm, launched its Hemoglobin A1c (HbA1c) Test, an at-home HbA1c test accessible via its Chronomics direct-to-consumer store. This Hemoglobin A1c Test is supplied as a home collection kit featuring finger-prick lancets and a sample card or tube, secure registration through a personal dashboard, and courier return to partner CLIA-certified labs. The service ensures lab-grade analysis with a typical turnaround of about three days following lab receipt, incorporates detailed result explanations, and provides optional direct access to healthcare professionals for subsequent care, effectively combining the ease of point-of-care or home sampling with the precision and standardization of central laboratory assays.

Which Major Industry Participants Are Leading The Hemoglobin A1c Testing Devices Market Growth?

Major companies operating in the hemoglobin a1c testing devices market are Arkray Inc, Abbott Laboratories, Polymer Technology Systems Inc, Bio-Rad Laboratories Inc, Menarini Group, F Hoffmann-La Roche AG, Siemens Healthineers AG, Tosoh Corporation, Trinity Biotech plc, Transasia Bio-Medicals Limited, Beckman Coulter Inc, Diazyme Laboratories Inc, EKF Diagnostics Holdings plc, HemoCue AB, OSANG Healthcare Co Ltd, Danaher, Thermo Fisher Scientific Inc., PTS Diagnostics India Private Limited, Nova Biomedical, Randox Laboratories Ltd., ACON Laboratories Inc., DiaSys Diagnostic Systems GmbH, Erba Mannheim, Green Cross Medical Science Corp., Infopia Co. Ltd., TaiDoc Technology Corporation, Werfen, Zhejiang Orient Gene Biotech Co. Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/hemoglobin-a1c-testing-devices-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Hemoglobin A1c Testing Devices Market?

North America was the largest region in the hemoglobin A1C testing devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the hemoglobin A1C testing devices market during the forecast period. The regions covered in the hemoglobin a1c testing devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Hemoglobin A1c Testing Devices Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9077&type=smp

Browse Through More Reports Similar to the Global Hemoglobin A1c Testing Devices Market 2026, By The Business Research Company

Hemoglobin A1C Hba1C Testing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemoglobin-a1c-hba1c-testing-global-market-report

Hemoglobin Testing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemoglobin-testing-global-market-report

Hematocrit Test Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hematocrit-test-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company